MALARIA CONTROL FROM THE INDIVIDUAL TO THE COMMUNITY

Similar documents
Symptoms of Malaria. Young children, pregnant women, immunosuppressed and elderly travellers are particularly at risk of severe malaria.

Malaria DR. AFNAN YOUNIS

Invest in the future, defeat malaria

Malaria. An Overview of Life-cycle, Morphology and Clinical Picture


Counting Malaria Out: Progress of Efforts in the Americas and More Stories of Innovations. Counting Malaria Out in the Americas

Malaria. Population at Risk. Infectious Disease epidemiology BMTRY 713 (Lecture 23) Epidemiology of Malaria. April 6, Selassie AW (DPHS) 1

University of Veterinary and Animal Sciences, Bikaner), V.P.O. Bajor, Dist. Sikar, Rajasthan, India

Anti-Malaria Chemotherapy

Running head: VECTOR-BORNE DISEASE 1

INTERVENTION MODEL OF MALARIA

40% (90% (500 BC)

The Malarias: Plasmodium falciparum Plasmodium vivax Plasmodium malariae Plasmodium ovale. Distribution of Plasmodium falciparum

Malaria. Edwin J. Asturias, MD

Title: Author: Benji Mathews. Date: 1/4/08. Key words: Malaria, Travel, Medications

Lesson 1:Introduction To Malaria INTRODUCTION. Contents. Objectives. From WikiEducator

Transmission network dynamics of Plasmodium Vivax Malaria

The Malarias: Plasmodium falciparum Plasmodium vivax Plasmodium malariae Plasmodium ovale. Watersheds of the African Continent

Protozoan Infections of the Circulatory System *

PARASITOLOGY CASE HISTORY #14 (BLOOD PARASITES) (Lynne S. Garcia)

I. F. A. L. P. A. Malaria information for pilots. Briefing Leaflet. Medical. The Global Voice of Pilots

Alberta Health Public Health Notifiable Disease Management Guidelines July 2012

ESCMID Online Lecture Library. by author

Malaria Updates. Fe Esperanza Espino Department of Parasitology Research Institute for Tropical Medicine

A COMPARATIVE STUDY OF QUININE V/S ARTESUNATE IN SEVERE MALARIA PATIENTS IN NORTHWESTERN RAJASTHAN, INDIA

Uganda MALARIA: AN OVERVIEW Species Lifecycle of Plasmodium Exoerythrocytic (asymptomatic stage): Step 1: Step 2: Step 3:

Interpretation of the World Malaria Report Country Profile

Malaria. benign (mild) malaria

5/11/2009. Information About Malaria. What is Malaria? How many people think Malaria is caused by mosquitoes? Evolution & History

Parasitic Protozoa, Helminths, and Arthropod Vectors

Advisory on Malaria. What is Malaria? 21 November Malaria is a serious, lifethreatening

Malaria Life Cycle Life Cycle

Blood Smears Only 5 February Sample Preparation and Quality Control 13B A

Plasmodium Vivax Malaria Transmission in a Network of Villages

L3-Malaria: Epidemiology, clinical management and control. 19 January 2018 SCBM346 TROPICAL INFECTIOUS DISEASES AND CONTROLS

HEMOPOIETIC SYSTEM INFECTIONS BACTERIAL INFECTIONS OF THE BLOODSTREAM Reading Assignment: Chapters 50 & 63

Malaria. is a mosquito-born disease causing about 3 million deaths a year world-wide. Many are children under the age of 5.

LESSON 3.2 WORKBOOK. Lesson 3.2: Reservoirs and vectors - Lyme disease and Malaria

Diagnosis of Infectious Agents in the Peripheral Blood Smear. Meredith Reyes, MD July 24, 2006

Topical and spatial repellents: where are we?

Malaria. Traveler Summary. Key Points. Introduction. Risk Areas

Malaria: Prevention remains our best measure for controlling the disease

Malaria and Global Warming. Jocelyn Maher & Mickey Rowe

Elements for a public summary

Some Mathematical Models in Epidemiology

Trends of malaria prevalence in under-five s and pregnant women at Kasama general hospital, Kasama district, Northern Zambia

Maloff Protect 250mg/100mg tablets Atovaquone/proguanil hydrochloride

LESSON 3.2 WORKBOOK. Reservoirs and vectors Lyme diseases and Malaria

AMREF DIRECTORATE OF LEARNING SYSTEMS MALARIA PREVENTION, CONTROL AND MANAGEMENT

Knowledge is power: 815 Second Avenue New York, NY Toll Free HEAL

Prevalence and risk factors of asymptomatic malaria among under-five children in Huye District, Southern Rwanda

Malaria Prevalence among Children in Abuja

Malaria Bad Air. Sarah K. Parker, MD Associate Professor of Pediatrics and Pediatric Infectious Diseases

Average Household Size and the Eradication of Malaria

Overview of Malaria Epidemiology in Ethiopia

World Health Day Vector-borne Disease Fact Files

MALARIA & TRAVEL MEDICINE

Increase in temperatures in Africa, rise in humidity creating new water sources and the start of agriculture in the Middle East and North East Africa

Odyssean malaria outbreak at a bush lodge in Madikwe Game Reserve, North West Province, October-November 2015

Ph.D. Thesis: Protective immune response in P.falciparum malaria 2011 CHAPTER I: Introduction. S.D. Lourembam 16

Malaria. by Dr. Ratnakar P. Kini

PARASITOLOGY CASE HISTORY #11 (BLOOD PARASITES) (Lynne S. Garcia)

Anas Raed. - Zaid Emad. - Malik Zuhlof

- Shahd Alqudah. - Moayyad Al-Shafei. - Malik Zihlif. 1 P a g e

Blood Smears Only 07 February Sample Preparation and Quality Control 12B A

The President s Malaria Initiative (PMI) Indoor Residual Spraying (IRS) in Motion: Malaria Stories from the Field

to change size? Abstract Introduction

Malaria: The Global Challenge. Diploma Thesis

The where, when and who of preventing malaria in travellers

Media centre Malaria. Key facts. Symptoms

Comparison of light microscopy and nested PCR assay in detecting of malaria mixed species infections in an endemic area of Iran

Cases of Severe Malaria and Cerebral Malaria in Apam Catholic Hospital and Manhiya District Hospital

JMSCR Vol 04 Issue 04 Page April 2016

ACCEPTED. Diseases, Monash University, Commercial Road, Melbourne, Victoria 3004, Australia

MALARIA CONTROL as a best practice Corporate Social Responsibility Programme

Where is Yellow Fever found?

Malaria. Dr Zia-Ul-Ain Sabiha

Repellent Soap. The Jojoo Mosquito. Africa s innovative solution to Malaria prevention. Sapphire Trading Company Ltd

ATOVAQUONE PROGUANIL INFORMATION FOR THE PATIENT

Journal Assignment #2. Malaria Epidemics throughout the World

FACTS. Approximately 2.48 million malaria cases are reported annually from South Asia. Of Which 75% cases are contributed by India alone.

Summary World Malaria Report 2010

Blood Smears Only 6 October Sample Preparation and Quality Control 15B-K

REPORT OF THE observation of the WORLD MALARIA DAY 2017 PARUL UNIVERSITY

Copenhagen, Denmark, September August Malaria

Travel Medicine. Simin Torabzadeh MD, FACP University of California, Irvine

Looking Into Malaria. Parkland College. Ahmad Ahmad Parkland College. Recommended Citation

DISTANCE LEARNING ANSWER SHEET Please circle the one best answer for each question.

Fabio T M Costa, PhD. University of Campinas (UNICAMP); Campinas, SP, Brazil. Supported by:

HUMASIS MALARIA ANTIGEN TEST HIGH SENSITIVE DIFFERENTIAL DIAGNOSIS OF MALARIA INFECTION

Malaria: A Global Perspective and Prospects for Elimination. Rima Shretta

MALARIA P. FALCIPARUM / P. VIVAX

Disclosure Information

Malaria and vaccination: an update. Robert Sauerwein Dept. of Medical Microbiology Radboud University Medical Center, Nijmegen, the Netherlands

Managing malaria. Scenarios. Scenario 1: Border provinces, Cambodia. Key facts. Your target region: Cambodia /Thailand border

Introduction to Global Child Health Elective for Pediatric Residents and Fellows Children s National Medical Center, Washington, DC.

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centers: Indication: Treatment: Objective: Primary Outcome/Efficacy Variable:

Swaziland National Malaria Elimination Policy

Yellow fever. Key facts

Pacifica, Pilot Synod, 2011

Transcription:

MALARIA CONTROL FROM THE INDIVIDUAL TO THE COMMUNITY Calvin L. Wilson MD Clinical Professor of Family Medicine and Public Health University of Colorado Anschutz

OBJECTIVES 1. Understand the unique characteristics of malaria infection, and how this can affect control measures 2. Review the recommended prevention and treatment measures for an individual infected with malaria 3. Describe the community-based experience of malaria control in Rwanda 4. Discuss the traditional measures of malaria control, and compare with new innovations in control

BURDEN OF ILLNESS Found in almost all equatorial countries, as far south as South Africa, and as far north as southern Turkey Estimated over 200 million symptomatic episodes/year Over 100 million in Sub-Sahara Africa As many as 2 million deaths/year, 75% in children and infants.

DISTRIBUTION OF MALARIA

PATHOPHYSIOLOGY Parasitic infection caused by one of 4 species of Plasmodium vivax, malariae, ovale, falciparum Depends on Anopheles mosquito (2 species primarily) as vector, and mammals as intermediate host, primarily man Unique life cycle Sexual in mosquito (male and female gametocytes) Asexual and cyclic in mammal (man)

PATHOPHYSIOLOGY Within man, several parallel cycles in liver, development of hypnozoites (vivax & ovale) and merozoites within erythrocytes, formation of merozoites and rupture of infected RBC produces typical cycles of fever and prolonged infections

PATHOPHYSIOLOGY Hypnozoites thought to be a latent, quiescent infection - may lay dormant and asymptomatic for many years - documented as long as 30 years Some merozoites mature into gametocytes sexual forms that begin cycle in Anopholes gut when ingested Gametocytes ingested by mosquito and mature into infective sporozoites, which are injected into host with blood meal

LIFE CYCLE OF PLASMODIUM

PATHOPHYSIOLOGY Type of erythrocyte invaded depends on species of Plasmodium vivax & ovale - primarily only young RBC (reticulocytes) - limited in number malariae - mainly older, senescent RBC falciparum - any RBC - can lead to high parasitic burden

ANOPHELES MOSQUITO

ANOPHELES MOSQUITO Found world wide, mainly in tropical and semitropical area - dependent on humidity and temperature Sporogony (formation of infective sporozites) dependent on ambient temperature - between 16-33 degrees Celsius Longevity of Anopheles dependent on relative humidity - longer in more humid environments

ANOPHELES MOSQUITO Only certain species capable of transmitting malaria - 1-2 infective types in each area - only female infective Generally found below 3500 ft altitude, but occasionally found as high as 7000 ft. Average life span about 30 days, flight pattern limited to about 300 meters Sexual phase of Plasmodium - 8-10 (range 8-16) days to complete in gut of Anopheles Mature mosquito infective only about 10-14 days.

DIAGNOSIS OF MALARIA Diagnosed by clinical picture in endemic area Rapid slide test shows antibody formation in early stage Up to 90% sensitive, less so in endemic area Gold standard thick blood smear May require multiple smears for diagnosis in cases of low parasitemia 1 smear 40-50% sensitive 3-4 smears - 90% sensitive

INDIVIDUAL PREVENTION OF MALARIA Reduce biting of Anopheles long sleeves and slacks personal insect repellents avoid use of cosmetics and perfumes mosquito coils and space repellents screens on windows and doors use of insecticide treated mosquito nets for naps and sleep

INDIVIDUAL PREVENTION OF MALARIA Medication prophylaxis - areas of chloroquine sensitivity or R-1 resistance Chloroquine 300 mg base/week (500 mg chloroquine phosphate) must continue for 4 weeks after leaving area Areas of chloroquine resistance: Mefloquine 250 mg/week begin 1 week before prior and continue for 4 weeks after leaving area

INDIVIDUAL PREVENTION OF MALARIA Areas of chloroquine resistance (contd): Doxycycline 100 mg daily or tetracycline 500 mg qid begin 1-2 days prior and continue 4 weeks after leaving area) Malarone (atovaquone 250 mg/proguanil 100 mg) 1 tablet daily begin 1-2 days prior and continue 7 days after leaving area

COMMUNITY PREVENTION OF MALARIA Still mainstay of public health measures Most effective when a combination of measures used: 1. Reduce burden of Anopheles periodic spraying of interior of dwellings with residual insecticide draining of pools of stagnant water use of larvacidal fish in pools or bacteria

COMMUNITY PREVENTION OF MALARIA 2. Prevent contact with Anopheles with insecticide-treated bed nets (ITN) 3. Reduce burden of parasitemia in the population by early identification and treatment of all cases, regardless of severity 4. Use of artemether agents effective sterilization of blood of Plasmodium

MALARIA IN RWANDA - 2005 35% of all deaths in children <5 30% of admissions to district hospitals CHW allowed only to take thick smear for suspected malaria not to treat Patients had to go to district hospital for treatment and often only after smear positive (4-6 hours minimum)

CONTROL MEASURES INSTITUTED 2009 In addition to community education, ITN for ALL family members, and targeted mosquito spraying 80% all households with ITN All CHW trained in early diagnosis of malaria by symptoms, and given Rapid slide tests Artemether/Lumefantrine adult and pediatric Community members instructed to visit CHW at first sign of headache, malaise, and fever

RESULTS OF COMMUNITY CONTROL IN RWNADA 2005-2012 Malaria incidence reduced by 66% across country up to 85% reduction some areas Rate of hospitalizations for malaria reduced by 7080% Incidence of death in children <5 reduced by 6570%.

MALARIA INCIDENCE BY APPROACH

BENEFITS OF COMMUNITY CONTROL OF MALARIA Community investment in control process Most of control process completed within the community, not in distant hospitals. Progressive decrease in reservoir of Plasmodium humans, which leads to: Logarithmic decrease in incidence of infection Less dependent on mosquito control

CHALLENGES OF COMMUNITY CONTROL OF MALARIA Human resource intensive especially training of adequate numbers of CHW (40,000 in Rwanda alone) Logistics intensive continual supplying all CHW with rapid slide tests and medication Expensive rapid slide tests about 5-10 times cost of thick smear analysis

CONCLUSIONS Malaria a multi-faceted problem with multiple potential points of control Recognition and management of malaria in the individual is well described and effective when begun promptly Individual control is feasible and effective, BUT Population/community control of malaria, especially directed toward reducing the human reservoir of Plasmodium, is even more effective.